July 1, 2026 · Form 4 insider transaction
Fox Jonathan C bought 319 shares of Edgewise Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.